Thursday, 24 March 2016
Stryker receives FDA clearance for 3-D printed spinal fusion implant
Stryker announced FDA clearance of the 3-D printed Tritanium PL Posterior Lumbar Cage, marking another step in its strategy to deploy the new additive manufacturing technology to create new products and earn incremental revenue growth.
The device is made from novel, highly porous titanium material designed for bone ingrowth and fixation in spinal conditions like degenerative disc disease, grade I spondylolisthesis, and degenerative scoliosis, the company said in a release.
To be commercialized in Q2 2016, the lumbar cage is intended for use with autografts and/or allogenic bone grafts, as well as supplemental spinal fixation systems.